🔎 Trials Near Me

Home › Cancer (all types) › Florida › Orlando

Cancer (all types) clinical trials in Orlando, FL

24 studies for Cancer (all types) are looking for participants at sites in and around Orlando (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Registry Study for Radiation Therapy Outcomes

RecruitingObservational study
  • Orlando Health Cancer Institute, Orlando
All ages · All sexes · Updated Sep 29, 2026 · NCT01255748

A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors

RecruitingPhase 1
  • GSK Investigational Site, Reunion · 23 mi away
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07277270

Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

RecruitingPhase 3
  • Advent Health, Orlando
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07195591

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

RecruitingPhase 3
  • Orlando Health Cancer Institute /ID# 280418, Orlando
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07365241

Visugromab in Cachexia International Trial

RecruitingPhase 2/3
  • Clermont Oncology Center, Clermont · 24 mi away
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07112196

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

RecruitingPhase 3
  • Orlando Health Cancer Institute, Orlando
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06119581

KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)

RecruitingPhase 2
  • Clermont Oncology Center ( Site 0041), Clermont · 24 mi away
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT07252739

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

RecruitingPhase 3
  • Advent Health - Orlando, Orlando
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06072612

Project: Every Child for Younger Patients With Cancer

RecruitingObservational study
  • AdventHealth Orlando, Orlando
  • Arnold Palmer Hospital for Children, Orlando
  • Nemours Children's Hospital, Orlando
Up to age 25 · All sexes · Updated Aug 25, 2026 · NCT02402244

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

RecruitingPhase 1/2
  • AdventHealth Celebration, Celebration · 17 mi away
Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT05592626

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

RecruitingPhase 3
  • Orlando Health Cancer Institute, Orlando
  • Health Central, Ocoee · 10 mi away
Ages 18 and older · All sexes · Updated Aug 7, 2026 · NCT06580314

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

RecruitingPhase 1/2
  • Clermont Oncology Center, Clermont · 24 mi away
Ages 18 and older · All sexes · Updated Jul 29, 2026 · NCT04198766

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

RecruitingPhase 1/2
  • Orlando Health UF Health Cancer Center, Orlando
Ages 12 and older · All sexes · Updated Jul 14, 2026 · NCT05533697

A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)

RecruitingPhase 1
  • GSK Investigational Site, Orlando
Ages 18 and older · All sexes · Updated Jun 25, 2026 · NCT06431594

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

RecruitingPhase 1/2
  • Orlando Health Cancer Institute, Orlando
Ages 18 to 70 · All sexes · Updated Jun 11, 2026 · NCT05361174

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

RecruitingPhase 1
  • Research Site, Orlando
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT06835569

Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer

RecruitingPhase 2
  • Clermont Oncology Center, Clermont · 24 mi away
Ages 18 and older · All sexes · Updated Jun 4, 2026 · NCT06463665

Serious Gaming for Chemotherapy-induced Nausea and Vomiting

Recruiting
  • Orlando Health, Orlando
Ages 60 and older · All sexes · Updated May 1, 2026 · NCT05838638

A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

RecruitingPhase 1
  • AdventHealth Cancer Institute, Celebration · 17 mi away
Ages 18 and older · All sexes · Updated Mar 20, 2026 · NCT05948865

GEMINI-NSCLC: NSCLC Biomarker Study

RecruitingObservational study
  • Clermont Oncology Center, Clermont · 24 mi away
Ages 18 and older · All sexes · Updated Feb 5, 2026 · NCT05236114

Beat Childhood Cancer Specimen Banking and Data Registry

RecruitingObservational studyHealthy volunteers welcome
  • Arnold Palmer Hospital for Children, Orlando
All ages · All sexes · Updated Feb 3, 2026 · NCT04715178

Caris Biorepository Research Protocol

RecruitingObservational studyHealthy volunteers welcome
  • Advent Health, Orlando
Ages 18 and older · All sexes · Updated Jan 21, 2026 · NCT01499394

Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy

RecruitingObservational study
  • AdventHealth Cancer Institute, Orlando
Ages 18 and older · Women · Updated Jan 29, 2025 · NCT04957511

Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing Cancer

RecruitingObservational study
  • University of Central Florida, Orlando
Ages 18 and older · All sexes · Updated Dec 6, 2024 · NCT06148298

About Cancer (all types)

If you or someone you love has been diagnosed with cancer, learn about diagnosis, treatment, risk factors, coping and much more.

More about Cancer (all types) on MedlinePlus

Cancer (all types) trials in other cities

Other studies in Orlando

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.